View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Kate Blakeman has become President Elect and James Crabtree, Junior Vice President.
Imogen (pictured) graduated from the RVC in 2000 and became a first opinion equine vet.
She was awarded RCVS Equine Medicine Advanced Practitioner status in 2014 and gained her Post Graduate Certificate in Veterinary Professional Studies and Stud Medicine Certificate in 2023.
Whilst working full-time in first opinion equine practice, she performs several other roles: VetGDP advisor, veterinary undergraduate teaching and examining, and RCVS Advanced Practitioner assessor.
Imogen is currently Chair of BEVA’s Ethics and Welfare Committee and a member of BEVA’s Education Committee.
Imogen said: “I have loved my experience on BEVA Council over the past few years, not least as Ethics and Welfare Committee chair.
"I have strong opinions and am brave enough to pop my head above the parapet to encourage conversation around topics I am passionate about.
"As a first opinion equine practitioner I hope I can bring a practical perspective to the table.
"I honestly never thought I would have the opportunity for the prestigious role of President - I hope it will inspire others to put themselves forwards.”
www.beva.org.uk.
Photo: @JasSansi
Seven veterinary surgeons who took their final assessments at the University of Liverpool on 6 September have become the first to receive the postgraduate RCVS Certificate in Advanced Veterinary Practice with equine designations.
Dr Mark Holmes, a member of the RCVS sub-committee for the CertAVP who observed the assessments at Liverpool said: "I was very impressed by the quality of all the candidates and the diligence of the examination process.
"It is clear that candidates putting themselves forward for 'named' certificates have demonstrated particular interest in their chosen fields and place considerable value on passing their synoptic examination."
The modular certificates were introduced in 2007 to be a more flexible replacement for the old-style postgraduate certificates. Vets can now choose from 79 subject modules, with RCVS-accredited assessments offered by a range of universities. These institutions may also offer associated courses which vets can take to support their studies, although candidates are free to choose where and how they wish to study.
To build their credits into the full CertAVP qualification candidates must first enrol with the RCVS, which keeps a record of modules achieved. Candidates need to take two compulsory modules, and several of a range of optional modules, within ten years in order to receive the award. Candidates aiming for a designated award must choose specific modules from amongst the options, and additionally pass an overarching 'synoptic' assessment.
For more information about the individual modules and the qualification as a whole, prospective candidates can visit www.rcvs.org.uk/modcerts.
There have been major changes to the format for Congress this year.
Sarah Fitzpatrick, BSAVA Head of Partnerships and Events, said: “Last year’s online event proved this can all be delivered in a much more interactive and engaging way.
"Returning to a face-to-face format enables us to take that even further and provide delegates with a truly immersive experience."
Many of the sessions at this year’s event will have two speakers delivering different perspectives on a topic, followed by a Q&A.
With 15-20 minutes to get into the detail, lectures will get straight to the point, be fast-paced and rich in content.
Programme committee lead, Paul Higgs (pictured right) said: “Each subject will be delivered in a mix of formats, lectures, debates and interactive sessions, for example.
"It means delegates won’t find themselves sat for hours passively listening, instead they’ve the opportunity to actively engage with the topics, which will promote deeper learning.
“Where topics overlap subject areas, module delegates will come together to explore diagnostics, treatments and ethics.”
For the first time, delegates will also be able to get hands-on in practical sessions at no further cost.
BSAVA’s President, Sheldon Middleton, said: “I can’t wait to get to BSAVA Congress in 2022.
"The new venue, new format and new exhibition layout will enhance everything that BSAVA Congress is known for.
"Now we’ve got a hybrid format, the on-demand feature means that for the first time I can catch up with friends and not miss the CPD!”
Delegates can also attend online, through an interactive virtual platform, which will run alongside the live event.
To buy your tickets before the touts get hold of them visit: https://www.bsavaevents.com/bsavacongress2022/en/page/home.
The data was presented at the 6th International Veterinary Pain Short Course hosted at NC State College of Veterinary Medicine.
VTX-304 is a bispecific antibody designed to target NGF and ADAMTS-5.
In a natural OA model with aged Beagles with a mean age of 10.8 years, VTX-304, dosed at 2.5 mg/kg SC, delivered pain relief comparable to the anti-NGF monoclonal antibody bedinvetmab, as measured by the modified Canine Brief Pain Inventory.
VetrixBio says that in biochemical and cell-based studies, VTX-304 demonstrated potent NGF/TrkA pathway inhibition and effective blockade of ADAMTS-5-mediated aggrecan cleavage, consistent with cartilage protection.
Peter Hanson, Chief Scientific Officer at VetrixBio, said: "Pain and OA in dogs are multifactorial. Single-pathway therapies leave significant disease biology unaddressed.
"VTX-304 represents an important advance, anchoring analgesia to diseased joint biology while protecting cartilage integrity.
"These initial results show that our bispecific antibody has the potential to deliver superior therapeutic profiles in veterinary medicine."
https://www.vetrixbio.com
London's Savile Row was turned into a sheep field today, to highlight The Campaign For Wool; a coalition of industry groups convened by HRH The Prince of Wales to educate consumers about the benefits of wool.
As the sheep grazed, the Row's famous tailoring houses held events where the public could find out more about the natural, sustainable qualities of wool.
Douglas Cordeaux, Managing Director of West Country woollen mill Fox Brothers, one of the organisations behind the promotion said: "We have a collective responsibility to champion this versatile, sustainable and natural fibre, the production of which involves far lower carbon emissions than man‐made alternatives. We need to support farmers who are the custodians of our rural landscape and truly value the qualities of this wonderful resource, which is used to weave the finest luxury cloth you can buy."
John Thorley of the Campaign for Wool said: 'I'd like to see wool re-established as a fibre of consequence where workers get paid properly and people recognise that this animal is useful to the farming sector in a multitude of ways.'
For more information, see www.campaignforwool.org and www.savilerowfieldday.com
Applications are now open for new members to join the RCVS Preliminary Investigation and Disciplinary Committees.
This is the first time that non-Council members have been able to sit on these two key committees, and follows the approval of a Legislative Reform Order (LRO) to the Veterinary Surgeons Act, which comes into force on 6 April 2013.
Under the new legislation, the two statutory committees will move through a transition period until they completely comprise independently-appointed non-Council members, by July 2015.
This move will provide regulation in line with modern practice, by ensuring that the same group of people is not responsible for setting the rules, investigating complaints and adjudication, and by bringing lay people formally into the Preliminary Investigation Committee.
The LRO will also allow the RCVS to increase the pool of people available to investigate complaints and sit on disciplinary hearings, reducing the workload on the individual Committee members whose primary appointment is to RCVS Council.
This first recruitment phase seeks:
RCVS President, Jacqui Molyneux said: "It's exciting that we can now seek to appoint non-Council members to the two committees involved in our disciplinary system - a breakthrough that has taken a long time to achieve.
"We are interested to hear from veterinary surgeons and lay people who are keen to contribute to the public good and support us in our regulatory role. It's an excellent opportunity to be part of the next chapter of the RCVS, as we become a more modern and effective regulator."
The recruitment process is being handled by Thewlis Graham Associates and details can be found at www.thewlisgraham.com. The selection committee will comprise Sir Michael Buckley, Christopher Laurence MBE QVRM TD BVSc MRCVS and Dr Joan Martin MA FCOT.
The closing deadline for applications is 5pm on Monday 4 March 2013.
Virbac has announced the launch of a new support pack to help practices promote National Microchipping Month this June.
The pack contains a range of promotional and educational items including:
Sarah Walker MRCVS, BackHome Product Manager, said: "With microchipping soon to become compulsory for dogs across the UK, this year's National Microchipping Month is the ideal platform to raise awareness of its importance in all species and to remind clients that they will soon be required by law to ensure that their dogs at least are protected with a microchip. The new BackHome Mini Chip has a 34% smaller needle than our standard needles and this can minimise any stress and discomfort to pets during implantation.
"The resources in our Microchipping Support Pack are bold, colourful and eye-catching. We hope that, with the creative teams that exist within each practice, you can promote National Microchipping Month successfully using imaginative displays and use this opportunity to engage with your clients."
For more information, contact your Virbac Territory Manager.
Providing a service for everyone from the richest to the poorest, veterinary surgeons probably have a better insight than most to the effects of inequality in society.
Whilst most people can probably think of one or two government policies which contribute to inequality, Sebastian's fully-referenced book is perhaps the first to identify the entire alphabet's worth, and collate them in an easily digestible format (it's only a 45 minute read).
The book is available in hardback on Amazon for £10, or as an e-book for £5.99
Sebastian is on VetSurgeon.org to answer your questions about and discuss how government policies create inequality in society, here: https://www.vetsurgeon.org/001/nonclinical/f/off-duty-discussions/30455/the-a-z-of-inequality
Although you certainly don't have to have bought or read his book to take part in the discussion, you should find it £5.99 well spent.
https://www.amazon.co.uk/Z-Inequality-Sebastian-Chambers-ebook/dp/B09ZVN1HDW
The BSAVA has announced a partnership with the University of Liverpool to develop a national UK disease surveillance network for companion animals.
Originally established in 2008, the Small Animal Veterinary Surveillance Network, SAVSNET, aimed to monitor the disease status of the UK small animal population (mainly dog, cat and rabbit). However, funding for the project came to an end in August 2011. At this point, BSAVA stepped in with support, as it believed that not only would the profession benefit from this source of information, but that it is in fact vital for the successful management of disease in small animals.
BSAVA President Andrew Ash said: "SAVSNET ticks all the boxes for BSAVA. High quality large scale epidemiological research helps us fulfil our obligations as a charity to public good, the information on disease surveillance gives us the information to treat animals better, and the research papers help us inform veterinary policy and education. This is an important scheme for both animal and human health."
Participation by diagnostic labs and practices is voluntary, and all data gained will be made anonymous before being reported. For more information, email savsnet@liverpool.ac.uk.
Improve International has announced the launch of a new General Practitioner Certificate in Dermatology: GPCert (Derm).
The company says the programme aims to help vets develop their knowledge of dermatology and to assist them in applying these newly learned skills in their everyday dermatology cases.
David Babington MRCVS (pictured right), Managing Director of Improve International said: "Patients with skin problems attend practices almost on a daily basis, making the successful diagnosis and management of skin disease a major component of small animal work and an important way to build client satisfaction and loyalty.
"Our new modular programme offers a thorough, informed case-based approach to dermatology. Through lectures, case discussions and, where appropriate, practical sessions, delegates will learn how to approach dogs, cats and exotic patients presenting with various manifestations of skin disease in a logical and scientific manner."
The GPCert (Derm) comprises 14 taught modules and can be completed over one to two years. The first module on this programme will start in March 2015.
For further information, visit www.improveinternational.com or call 01793 759159.
The company says that the number of studies related to the dog and cat microbiome has increased by over 800% between 2012 and 20221, but that practical implementation of the research lags behind.
The event will cover topics ranging from nutrition and faecal microbial transplantation (FMT) for chronic enteropathy to controversies in the use of gastric acid suppressants and the roles of the gut-brain and gut-kidney axes in disease.
Speakers include Jan Suchodolski, MedVet, DrVetMed, PhD, AGAF, DACVM, who has published more than 340 peer-reviewed manuscripts in the field of veterinary gastroenterology and the microbiome, Kathrin Busch, DVM, Dr Med Vet, DECVIM-CA, Head of Small Animal Gastroenterology at Ludwig-Maximilians University, and Jessica Quimby, DVM, DACVIM (SAIM), PhD, International Renal Interest Society (IRIS) board member and winner of the IRIS Award 2018.
https://www.microbiomeforumevent2023.purinainstitute.com
In November 2024, the RCVS Education Committee agreed to grant the veterinary degree conditional accreditation after an accreditation visitation earlier that year found deficiencies with the degree meant it only met 27 of the 77 RCVS accreditation standards.
55 recommendations for improvement were made by the visitation panel.
A subsequent visit in September 2025 found that while there were still a significant number of standards to be met, many of the recommendations for improvement had either been achieved, or significant progress had been made towards them being met.
The Education Committee therefore decided to grant the programme conditional accreditation for one year, with an action plan and timetable being put into place to guide how and when the 20 outstanding recommendations would be met.
The next accreditation visit to Cambridge will take place in October 2026.
It was agreed that this timeframe and accreditation status would ensure that progress towards meeting accreditation standards continued at pace, allowing the Department to demonstrate its commitment to student wellbeing and support for learning across the entirety of the veterinary programme.
An RCVS spokesperson said: “We appreciate the considerable efforts and hard work that the staff team within the veterinary department at Cambridge University have put into rectifying many of the issues identified in the 2024 accreditation event, for taking on board the constructive advice that was given and working together to make many of the necessary improvements.
“However, as the report shows, there are still several outstanding areas of concern, and so the Education Committee agreed that it was not yet in a position to grant Cambridge’s veterinary degree full accreditation.
“We have collaborated with Cambridge on putting together an action plan and timeline for meeting the 20 remaining recommendations and we hope that it will continue on its current trajectory towards meeting the RCVS accreditation standards.”
https://www.rcvs.org.uk/document-library/university-of-cambridge-2025-report/
Photo: © Copyright John Sutton and licensed for reuse under this Creative Commons Licence.
A new study from the University of Surrey, published today in the journal PLOS One, has identified the specific effects of a malformation which affects affects toy breeds.
According to researchers, Chiari malformation has become prevalent as a result of selective breeding and affects many toy dog breeds which have been bred to look more doll-like, including Griffon Bruxellois, Cavalier King Charles Spaniels, Chihuahuas and their crosses.
Researchers took brain, skull and vertebrae measurements of 155 Griffon Bruxellois and compared dogs affected by the condition with normal Griffons. They discovered that Griffons with the disease had taller foreheads and that it had also caused the shape of the brain to change, with severely affected animals having their cerebellum pushed underneath the main part of the brain.
The researchers say that although it can be asymptomatic, in many dogs Chiari malformation can cause headaches, problems with walking or even paralysis.
The condition can also affect humans and the University is working with human geneticists at the University of Montreal, in the hope that better understanding of the condition will lead to improved treatment for both dogs and humans.
Lead author, Dr Clare Rusbridge from the new School of Veterinary Medicine at the University of Surrey, said: "Chiari malformation can be described as trying to fit a big foot into a small shoe. It can be very painful, causing headaches and pressure on the brain and can result in fluid filled cavities in the spinal cord. Our latest discoveries will be significant in driving this research forward and hopefully allow us to identify which genes may be associated with the condition.
"Our next steps will be to apply our technique to other breeds with Chiari malformation and investigate more sophisticated ways of screening, so that risk of disease can be detected more easily, at an earlier age and with a single MRI scan.
"We want to engage breeders and give them practical advice about the condition, but it is also important that the public recognises that breeding dogs in a certain way to influence how they look might not be in the animal's best interest. There are responsible breeders out there, who have invested in screening and who are breeding for health as well as producing attractive puppies, and it is vital that people only look to buy from them."
Novartis Animal Health has launched 'The Wormer Decision Tree', an online tool to help veterinary surgeons in giving sheep farmers the most up-to-date advice about worming.
Lesley Stubbings, SCOPS representative and Independent Sheep Consultant said: “Choosing the right wormer group is hugely important and there remains much confusion especially when it comes to anthelmintic resistance.
“Worms, including resistant and multi-resistant species, are threatening the productivity of sheep farms. However with a well-thought-out worming strategy that uses both the new wormer groups, in association with existing wormers, it is possible to slow resistance.”
Results of the Farming Against Wormer Resistance (FAWR) campaign survey, conducted in 2013, revealed growing concern about wormer resistance among farmers - but confusion about the best course of action to take.
Fiona Anderson, Novartis Animal Health Veterinary Manager said: "This tool has been developed adhering to SCOPS principles and is designed to ensure a consistent responsible approach is used when prescribing anthelmintics.
"Available only to SQPs and vets, it will be a valuable tool to train new staff and use with farmers, to explain which of the five drench classes are appropriate for particular sheep groups at specific times of year."
The Novartis Wormer Decision Tree asks three key questions: the type of sheep being dosed, the purpose of the dose, and the farm's resistance status. It then produces a recommendation of the required active ingredient, along with more detailed information to support the recommendation. There is also a calculator which provides a dose rate and cost per dose based upon the recommendation.
To use the decision tree, you must first register on the Novartis Farm Animal Health website: www.farmanimalhealth.co.uk. Then head here: www.farmanimalhealth.co.uk/wormerdecisiontree
The 45-minute webinar: Debt Management: Prevention Is Better Than Cure is presented by Mike Brooks from veterinary-specialist debt recovery agency, dsl.
VPMA President Renay Rickard (pictured right) said: "Debt can affect any business, but, because of the role vets play as care-giver in an emotionally-based animal-owner relationship, we are particularly vulnerable. This is something that is commonly brought up by members at our regional meetings and events, and it’s a real dilemma for them how to juggle being strict with payment policies against owner expectations and misperceptions of the cost of veterinary medicine.
"This has been a very popular topic in both our regional meetings and with our webinar and we wanted to open it up to more people to help them tackle this topic in their practices. The feedback on this webinar has been very positive. Mike gives clear guidance on how to set up payment protocols that will minimise debt in such a way that maintains the client-practice relationship. There’s also information on how to recover existing debts. It makes sense to prioritise tackling this issue as if we’re not paid, then we can’t deliver the service that we are expected to, and that our patients need.
"We’re pleased to open this webinar up to all practices as a Christmas gift, and hope it will also highlight the support that is available through VPMA membership."
The webinar can be accessed through a link on the home page of the VPMA website www.vpma.co.uk.
The panel, chaired by veterinary ethicist Professor David Morton CBE, was established last year on a trial basis as a means of offering an ethical review process for practice-based research projects that may not have the same access to resources as clinical studies in academia or industry.
Since its establishment at the end of July last year it has received 23 applications, mostly concerning small animal clinical studies. However, due to demand from the profession, it will shortly be considering applications for equine or farm animal-based research and will be recruiting new panel members to cover these areas.
Eleanor Ferguson, RCVS Registrar, said: "Although the number of cases considered so far have been relatively small, the service has been very well received as a means of providing ethical review to those who might not otherwise be able to do so and so, therefore, might struggle to get papers published.
"Considering the importance of practice-based research we expect there to be an increase in the number of applications as word gets out about the service and so are happy to extend the trial for another year and for it to consider a wider range of applications."
Further details about the Panel, as well as guidelines for making applications and the application forms, can be found at www.rcvs.org.uk/ethics
For an initial discussion about submitting an application to the Ethics Review Panel, contact Beth Jinks, Standards and Advisory Officer, on 020 7202 0764 or ethics@rcvs.org.uk
Sally Linghorn, Senior RVN at CVS and one of the team behind the initiative, said: “As far as we know, no other veterinary company has policy, support and specific training and guidance on this topic, in our female-biased profession.”
“We recognise how devastating pregnancy loss can be.
"Last year we launched a policy to provide special paid leave for pregnancy loss.
"But since implementing this we have noticed a gap.
"We felt our managers needed guidance and support on how to provide the more practical and emotional support on a day-to-day basis, if someone in their team experienced a loss."
The new guidance contains advice on how to understand each individual’s experiences and needs, help in the immediate situation of pregnancy loss at work, treat and record any time off directly related to a loss, understand how pregnancy loss can affect mental health, talk about pregnancy loss, facilitate a return to work and the importance of regular follow-ups and check-ins.
The Standards Framework for Veterinary Nurse Education and Training sets out the professional values, skills and behaviours required of approved educational institutions (AEIs), delivery sites and the training practices (TPs) responsible for providing the training and support for student veterinary nurses.
The College reviews the standards framework every five years to ensure that AEIs, delivery sites and TPs have the structures to best provide contemporary and innovative approaches to education for student veterinary nurses, while being accountable for the local delivery and management of accredited programmes.
The new draft framework includes updates relating to sustainability and academic integrity.
Julie Dugmore, RCVS Director of Veterinary Nursing, said: “We are looking for veterinary nurses in all walks of life – as well as student nurses and veterinary surgeons – to provide constructive and specific feedback on our proposals.
“Your insights will help us ensure that the standards continue to enable veterinary nurse educators to deliver the best training and support possible for our students, prepare them for life in clinical practice, and ensure that animal health and welfare is a foremost consideration.
“In fact, animal health and welfare and public safety is central to our standards.
Students will be in contact with patients and their owners throughout their education and it is important that they learn in a safe and effective way.”
The consultation runs until 5pm on Wednesday 3 April 2024 and all members of the veterinary team – including RVNs, student veterinary nurses and veterinary surgeons – can take part in order to provide detailed feedback on each of the six core standards and each of individual requirements within these standards.
A PDF version of the new draft Standards Framework is available to download from https://www.rcvs.org.uk/news-and-views/our-consultations.
If you have any questions about the document or how to respond to the survey, contact the RCVS Veterinary Nursing Team on vetnursing@rcvs.org.uk
The new hydrolysed diet contains hydrolysed proteins, AuraGuard, fibres and Zeolite.
Dechra says the new formula featured in both diets offers superior palatability and works in a multi-action way with support of the gut-kidney axis to help optimise protein absorption and maintenance of muscle mass, gut barrier integrity and a healthy microbiome, while lowering uremic toxins in the blood.
The company says both diets control levels of protein, phosphorus and sodium and offer high levels of the Omega-3 fatty acids EPA and DHA.
Becky Morris, marketing manager at Dechra, said: "Chronic kidney disease is a lifelong progressive disease in dogs and cats, and nutrition is an important part of management to help slow disease progression, improve quality of life and reduce the risk of secondary complications.
"Our new and updated highly palatable Specific Heart & Kidney Support diets will help keep dogs and cats in good condition, prolonging the progression of the disease and the lifespan of the pet."
https://www.specific-diets.co.uk
A European study undertaken in horses to evaluate the efficacy of the key anthelmintic molecules fenbendazole, pyrantel, ivermectin and moxidectin in treating equine cyathostomins, has confirmed that resistance is developing against all the molecules with the exception of moxidectin.
Resistance to fenbendazole was highlighted as a particular issue with 80% of the yards tested in the UK and Germany showing resistance. Resistance to pyrantel also proved to be increasingly prevalent while cases of ivermectin resistance were emerging.
The Fort Dodge-sponsored study, the largest of its kind so far undertaken, took place during 2008 and was led by scientific teams from veterinary faculties in Italy and Germany. It was based on Faecal Egg Count Reduction Tests (FECRTs) of 1,704 horses at 102 yards in Italy, Germany and the UK. The calculation of FECR data was performed employing bootstrap analysis of group arithmetic means.
The study concluded that:
According to Dr Donato Traversa from the University of Teramo, Italy, who headed up the field work, the results confirm that single and even multiple drug resistance in equine cyathostomins is an increasing challenge in all three countries with resistance to fenbendazole and pyrantel a particular concern.
He said: "Our research highlights the necessity for vets, owners and managers to use those anthelmintic molecules that remain most effective in a manner which preserves their efficacy for as long as possible."
Professor Georg von Samson Himmelstjerna from Hannover University of Veterinary Medicine, which participated in the research, added: "Given the strong impact that resistant cyathostomins are likely to have on horse welfare, future parasite control plans should be based on integrated measures, involving both the correct use of anthelmintics, such as administering the correct dosing according to the animals weight, and only using products in the species for which it is licensed, as well as other approaches such as adequate pasture hygiene, low stocking rates and mixed grazing with other animals.
"We call on all concerned with equine health and welfare to take an active role in planning and monitoring effective worm control programs."
Hill's Pet Nutrition has announced an average price reduction of over 5 per cent across almost 80 per cent of its product range from 1st March 2010.
The company says this is the first time in its history that such a big price reduction has been implemented, and it comes with a promise that superior nutritional quality won't be compromised.
The price cut comes following market research by Hill's which shows that after one of the deepest recessions in 50 years, more pet owners are becoming cost-conscious, and many are now buying their petfood in the grocery channel or mixing premium foods with economy products.
Another factor in decision-making for some pet owners is the cost per pack, particularly on the larger bag sizes. From April 2010, some Hill's Prescription Diet products will be resized to make them a more affordable purchase. Canine Prescription Diets c/d, d/d, i/d, k/d and j/d will be moved from a 14 Kg bag to a 12 Kg bag. Feline Prescription Diets c/d, k/d, r/d, i/d and s/d will be moved from a 2 Kg bag to a 1.5 kg bag. The price reduction will also be applied proportionately alongside the smaller bag size, so many clients should see a significant reduction at point of purchase. The smaller bags are also easier for practices to store and can increase frequency of client visits providing more opportunities to offer advice and support.
Blake Hawley, Hill's General Manager for UK and Ireland said, "We would like to thank vets, nurses and support staff for their continued support and dedication. Every pet needs and deserves a nutritional assessment and this price reduction will make it easier for vet teams to recommend the best Hill's product, confident those pets are getting high quality nutrition at new, lower prices. Having listened to what the profession had to say in 2009, this year we will demonstrate our commitment to the veterinary profession in very clear and visible ways."
For an up to date price list and support material to assist in communicating the change to clients, please contact your Hill's Territory Manager or call 0800 282438
Invicta Animal Health has launched EthyCalm Spray, a cryoanalgesic for minor procedures.
The active ingredient, ethyl chloride, acts as a local analgesic (pain relief) when sprayed or wiped onto the skin.
According to the company, the product is effective in a few seconds and works for a few minutes until the skin warms up again. This makes it suitable for such things as venepuncture, tick removal or placing of PVC's, where it should help reduce stress for the patient and the practitioner.
Ethycalm is presented in a 50ml vial which provides up to 100 applications.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to launch EthyCalm. During theatre training sessions for our product, ChloraPrep, we realised that the busy nurse doesn't have time to use traditional analgesia methods such as creams. They needed something instant yet cost-effective. Seeing the widespread use of ethyl chloride in places like Great Ormond Street Hospital, it was obvious that this product needed to be made available to veterinary practices".
For further information see www.invictavet.com or phone 01403 791313
CVS has announced that it is to support the Small Animal Veterinary Surveillance Network (SAVSNET), a charity initiative run jointly by the BSAVA and the University of Liverpool to monitor health and illness in companion animals using anonymised data from veterinary practices and laboratories.
The group will be linking its practices, of which there are now more than 290, to SAVSNET through their practice management systems in a rollout that will continue until the end of the year.
Through its research and analysis, SAVSNET aims to monitor disease trends over time; identify populations at risk and monitor treatments and outcomes. It also aims to provide data and improve public awareness of small animal diseases and prevention. One of its projects delivers near-real-time (within 24 hours) practice-based syndromic surveillance based on data received from participating veterinary surgeons, who through a single mouse click, record information at the end of each consultation through their practice management system. The data is automatically sent to SAVSNET for secure storage and analysis. The whole process is designed to avoid any impact on a practices already busy work flow.
Dr Alan Radford, one of SAVSNET’s principal investigators, said: "Reusing electronic health data has a massive potential to improve animal and human health. SAVSNET is one project leading the way in this research and it is great to be working with CVS, with its scale and also its focus on high quality veterinary care.
"Working together, SAVSNET and members of the CVS team can really help understand in a new way the diseases seen by the populations under our care. As a small thank you for participation, practices that take part are provided with a secure on-line portal where they can see free anonymised benchmarking statistics including disease data and antibacterial use. Greater knowledge will enable us to target interventions to those animals most at risk, to identify risk factors for disease and to focus veterinary research efforts."
Marcus Evans, Head of Practice Management Systems at CVS said: "We are very impressed at the projects being carried out by the SAVSNET team and are keen to support its work, particularly as our veterinary teams can do it so quickly and easily through RoboVet, our practice management system. As a large veterinary group, and one that is continuing to grow rapidly, our support will add significant weight to SAVNET's efforts and we are delighted to be contributing to such valuable research."